Target intelligence / Profile preview

Metabolic detoxification

Molecular classification
Enzyme, Transporter
01

Overview

Metabolic detoxification is a complex biological process by which the body, primarily through the liver, chemically modifies xenobiotics such as drugs and environmental toxins to facilitate their elimination [StatPearls, 2023]. This system is traditionally divided into three phases: Phase I involves functionalization (oxidation, reduction, or hydrolysis) often mediated by the Cytochrome P450 (CYP) enzyme superfamily; Phase II involves conjugation with polar moieties like glucuronic acid or glutathione; and Phase III involves the active transport of these metabolites out of cells via efflux transporters [Wikipedia, 2024; NIH, 2022]. While this pathway is essential for protecting the organism from chemical insult, it is also a major source of clinical challenges, including drug-drug interactions and the inadvertent production of reactive, toxic intermediates [Nature Reviews Drug Discovery, 2010]. Because "Metabolic detoxification" refers to a broad physiological pathway involving hundreds of distinct enzymes and transporters rather than a single molecular entity, it is classified as a biological process rather than a specific therapeutic target [PubChem, 2024]. Understanding this system is critical for drug development to ensure proper pharmacokinetics and to minimize the risk of drug-induced liver injury (DILI) [FDA, 2020].

Other names
Xenobiotic metabolismBiotransformationDrug metabolismPhase I, II, and III metabolismDetoxification pathway
02

Mechanism of action

Modulation of metabolic enzyme activity (induction or inhibition) and transporter function to alter the clearance, half-life, and toxicity of xenobiotics.

03

Biological functions

Xenobiotic metabolic processDetoxificationHomeostasisExcretion
04

Disease associations

Drug-induced liver injuryCancerToxicityMetabolic disorders
05

Safety considerations

Drug-drug interactionsHepatotoxicityMetabolic activation of pro-carcinogensTherapeutic failure due to rapid clearanceAccumulation of toxic metabolites
06

Interacting drugs

Rifampicin

5 more in the full profile.

07

Biomarkers

Alanine aminotransferase (ALT)Aspartate aminotransferase (AST)Glutathione levelsCytochrome P450 activityBilirubin

Beyond the preview

Go deeper on Metabolic detoxification.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metabolic detoxification.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call